Posted on

blueberry marijuana strain seeds standardized

We’ve mentioned that THC is known to slow down response times and reduce users’ ability to focus and concentrate. Although this can be a negative effect for some people, it’s a definite benefit for others. This is particularly true for people whose minds operate in hyperdrive as is the case with ADHD. THC may slow down their thought processes and calm their minds enough to improve their focus and attention spans.

The high, like the smell, is very zesty and uplifting. Great companion for creative ventures.

Fragrant and mouthwatering. Tease your palate with a burst of bubblegum.

Why Choose i49 Seed Bank for Your High-THC Marijuana Seeds

Remember, quality matters. Getting your seeds from just any supplier could leave you disappointed when your marijuana crop comes in if it grows at all. Turning to a reputable seed bank like us greatly improves your chances of success.

We offer several types of high-THC seeds that aren’t quite as fussy. Some have Ruderalis DNA in their genes, so they’re more tolerant than they would be otherwise. They’re also more resistant to pathogens. Autoflowering varieties are generally easier to grow than regular seeds, and they don’t require the same level of light regulation. If you’re a first-time grower or don’t have a great deal of time to devote to marijuana care, these may be your best bet.

Auto White Widow is an Indica dominant automatic flowering strain that delivers a moderate yield of creativity inducing flowers high in THC.

Clear your schedule for the biggest and baddest nuggets you will ever encounter.

04 déc. 2020 07h30 HE | Source: Blueberries Medical Corp. Blueberries Medical Corp.

These forward-looking statements are based on reasonable assumptions and estimates of management of the Company at the time such statements were made. Actual future results may differ materially as forward-looking statements involve known and unknown risks, uncertainties and other factors which may cause the actual results, performance or achievements of the Company to materially differ from any future results, performance or achievements expressed or implied by such forward-looking statements. Such factors, among other things, include: fluctuations in general macroeconomic conditions; fluctuations in securities markets; expectations regarding the size of the Colombian and international medical cannabis market and changing consumer habits; the ability of the Company to successfully achieve its business objectives; plans for expansion; political and social uncertainties; inability to obtain adequate insurance to cover risks and hazards; and the presence of laws and regulations that may impose restrictions on cultivation, production, distribution and sale of cannabis and cannabis related products in Colombia, Argentina and elsewhere; and employee relations. Although the forward-looking statements contained in this news release are based upon what management of the Company believes, or believed at the time, to be reasonable assumptions, the Company cannot assure shareholders that actual results will be consistent with such forward-looking statements, as there may be other factors that cause results not to be as anticipated, estimated or intended. Readers should not place undue reliance on the forward-looking statements and information contained in this news release. The Company assumes no obligation to update the forward-looking statements of beliefs, opinions, projections, or other factors, should they change, except as required by law.

The Purchase Agreement was amended to change its terms to reflect the payment of the purchase price to be satisfied by Blueberries issuing 3,000,000 common shares in the capital of the Company to the vendors.

TORONTO, Dec. 04, 2020 (GLOBE NEWSWIRE) — Further to its news releases dated March 26, April 4, and July 2, 2019, Blueberries Medical Corp. (CSE: BBM) (OTC: BBRRF) (FRA: 1OA) (the “Company” or “Blueberries“), a Latin American licensed producer of medicinal cannabis and cannabis-derived products is pleased to announce that the Company has completed the acquisition of BBV Labs Inc. (“BBV”), a corporation formed under the laws of the Republic of Panama, pursuant to the previously announced share purchase agreement (the “Purchase Agreement”).

Richmond, British Columbia, CANADA